Company · founded 1996
Biological Mimetics (United States)
Frederick, United States · biologicalmimetics.com/antigens_vaccines_antibodies
- Citations, last 5 years
- 166
- Works, last 5 years
- 21
- h-index
- 33
- Scientists listed
- 2
- Grants since 2016
- 17
Grants received
2025–2028 · contract · N43
FAST – CRISPR-based Diagnostic for Parasites
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2024–2026 · research · R43
An instrument-free malaria diagnostic
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2024–2026 · research · R43
A Subunit Vaccine Against Acinetobacter Baumannii
Stephen Jeffrey Dollery · Biological Mimetics (United States) · funded by National Institutes of Health
2024–2026 · research · R43
An instrument-free malaria diagnostic
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2023–2024 · contract · N43
CRISPR-based Diagnostic for Parasites
Gregory Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Development of a Staph Aureus Vaccine
Stephen Jeffrey Dollery · Biological Mimetics (United States) · funded by National Institutes of Health
2023–2025 · research · R43
Development of a Staph Aureus Vaccine
Stephen Jeffrey Dollery · Biological Mimetics (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Development of a Universal Influenza Vaccine
David A Macleod · Biological Mimetics (United States) · funded by National Institutes of Health
2020–2022 · research · R43
Development of a Universal Influenza Vaccine
David A Macleod · Biological Mimetics (United States) · funded by National Institutes of Health
2019–2021 · research · R43
Whole-Cell Vaccine Development for MRSA
Stephen Jeffrey Dollery · Biological Mimetics (United States) · funded by National Institutes of Health
2019–2020 · research · R43
Development of a cross-protective HRV vaccine
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2018–2020 · research · R43
Manganese-peptide Countermeasures for Radiation Exposure
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2018–2019 · research · R43
Improved RSV F Vaccine Candidates
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2015–2025 · research · R44
Nonclinical Development of an Improved Polio Vaccine
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2015–2026 · research · R44
Nonclinical Development of an Improved Polio Vaccine
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2015–2025 · research · R44
Nonclinical Development of an Improved Polio Vaccine
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health
2015–2020 · research · R44
Development of an improved, low-cost polio vaccine (Ir-IPV)
Gregory John Tobin · Biological Mimetics (United States) · funded by National Institutes of Health